DiaMonTech, a German technology company backed by Jindong Investment, won the top prize in the Entrepreneurship Competition in Germany on June 22.

 

On the night of June 22, the scientific research magazine BILANZ awarded the top prize to DiaMonTech in the Second Entrepreneurship Competition in Germany. DiaMonTech will receive EUR 100,000 (RMB 760,000) in prize money, annually followed and reported by Germany’s authoritative business magazine and powerfully followed and guided by Peter Thiel, founding father of Silicon Valley venture capital.

 

There were 243 startups participating in the competition. The DiaMonTech team presented its high-quality and innovative medical device to the political and business circles and the media – a testing device for measuring blood glucose through laser technology. The application of the technology would allow nearly 500 million diabetics worldwide to get rid of pesky needles and save expensive spending of consumables. Klaus Boldt, editor-in-chief of the scientific research magazine BILANZ, said: “DiaMonTech will set a new benchmark for medical technology through its innovation, and will also open up the markets worth of billions of dollars.”

 

Jindong Investment became the shareholder of DiaMonTech through capital increment in February 2017. The DiaMonTech’s non-invasive blood glucose project has achieved remarkable results in less than two years since establishment, and the award will help the project to obtain the attention and support from global top investors. Since its establishment, Jindong Investment has invested in emerging industries and excellent growth enterprises, and made full use of 20 years of industrial operation experiences and resources of Jindong Group to discover entrepreneurial teams and find out enterprises with innovative business models. At present, Jindong Investment has invested dozens of high-growth enterprises.